Cite
HARVARD Citation
Huillard, O. et al. (n.d.). Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients. Expert opinion on drug safety. pp. 663-673. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Huillard, O. et al. (n.d.). Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients. Expert opinion on drug safety. pp. 663-673. [Online].